Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 10, 2015, Pages 1230-1238

  Li, N ^a   Xie, W P ^a   Kong, H ^a   Min, R ^a   Hu, C M ^b   Zhou, X B ^c   Lu, Z M ^c   Ji, X H ^c   Wang, H ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING CHEST HOSPITAL   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CTLA 4; ICOS; MDR TB; PD 1; Treg cells

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSTATIC AGENT; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MALE; MULTICENTER STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS; UNIVERSITY HOSPITAL; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CTLA-4 ANTIGEN; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84942757876     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0148     Document Type: Article

References (30)

1. Gandhi N R, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375: 1830-1843.
2. Chatila T A. Role of regulatory T-cells in human diseases. J Allergy Clin Immunol 2005; 116: 949-959.
3. Mills K H, McGuirk P. Antigen-specific regulatory T cells-their induction and role in infection. Seminars in Immunology, 16. Amsterdam, The Netherlands: Elsevier, 2004: pp 107-117.
4. Ernst J D. The immunological life cycle of tuberculosis. Nature Rev Immunol 2012; 12: 581-591.
5. Guyot-Revol V, Innes J A, Hackforth S, Hinks T, Lalvani A. Regulatory T-cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Critical Care Med 2006; 173: 803-810.
6. Philips J A, Ernst J D. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 2012; 7: 353-384.
7. Scott-Browne J P, Shafiani S, Tucker-Heard G, et al. Expansion and function of Foxp3-expressing T-regulatory cells during tuberculosis. J Exp Med 2007; 204: 2159-2169.
8. Tan Q, Xie W P, Min R, et al. Characterization of Th1-and Th2-type immune response in human multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis 2012; 31: 1233-1242.
9. Kursar M, Koch M, Mittrücker H-W, et al. Cutting edge: regulatory T-cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 2007; 178: 2661-2665.
10. Harding C V, Boom W H. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nature Rev Microbiol 2010; 8: 296-307.
11. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl K B. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 2010; 207: 1409-1420.
12. Sharma P K, Saha P K, Singh A, Sharma S K, Ghosh B, Mitra D K. FoxP3+regulatory T-cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med 2009; 179: 1061-1070.
13. Burl S, Hill P, Jeffries D, et al. FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol 2007; 149: 117-122.
14. Singh A, Dey A B, Mohan A, Sharma P K, Mitra D K. Foxp3+ regulatory T-cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-c producing T-cells. PLOS ONE 2012; 7: e44728.
15. Green A M, Mattila J T, Bigbee C L, Bongers K S, Lin P L, Flynn J L. CD4+ regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. J Infect Dis 2010; 202: 533-541.
16. Lim H J, Park J S, Cho Y J, et al. CD4(+)FoxP3(+) T-regulatory cells in drug-susceptible and multidrug-resistant tuberculosis. Tuberculosis 2013; 93: 523-528.
17. Geffner L, Yokobori N, Basile J, et al. Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains. Infect Immun 2009; 77: 5025-5034.
18. Sharpe A H, Wherry E J, Ahmed R, Freeman G J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nature Immunol 2007; 8: 239-245.
19. Francisco L M, Sage P T, Sharpe A H. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010; 236: 219-242.
20. Amarnath S, Costanzo C M, Mariotti J, et al. Regulatory T-cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLOS BIOL 2010; 8: e1000302.
21. Ha S J, Mueller S N, Wherry E J, et al. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 2008; 205: 543-555.
22. Alvarez I B, Pasquinelli V, Jurado J O, et al. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J Infect Dis 2010; 202: 524-532.
23. Kaufmann S H. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect Dis 2011; 11: 633-640.
24. Conrad C, Gregorio J, Wang Y H, et al. Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells. Cancer Res 2012; 72: 5240-5249.
25. Busse M, Krech M, Meyer-Bahlburg A, Hennig C, Hansen G. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T-cells conveying respiratory tolerance. J Immunol 2012; 189: 1975-1982.
26. Sakthivel P, Gereke M, Breithaupt A, et al. Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells. PLOS ONE 2014; 9: e100970.
27. Nouailles G, Day T A, Kuhlmann S, et al. Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection. Eur J Immunol 2011; 41: 981-991.
28. Takahashi N, Matsumoto K, Saito H, et al. Impaired CD4 and CD8 effector function and decreased memory T-cell populations in ICOS-deficient patients. J Immunol 2009; 182: 5515-5527.
29. Paust S, Cantor H. Regulatory T-cells and autoimmune disease. Immunol Rev 2005; 204: 195-207.
30. Suzuki S, Konnai S, Okagawa T, et al. Increased expression of the regulatory T cell-associated marker CTLA-4 in bovine leukemia virus infection. Vet Immunol Immunopathol 2015; 163: 115-124.